Cite
HARVARD Citation
Rutten, I. et al. (2016). Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients. Journal of cachexia, sarcopenia and muscle. 7 (4), pp. 458-466. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rutten, I. et al. (2016). Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients. Journal of cachexia, sarcopenia and muscle. 7 (4), pp. 458-466. [Online].